These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 12051631)
1. Immunohistochemical localization of the IAP protein survivin in bladder mucosa and transitional cell carcinoma. Lehner R; Lucia MS; Jarboe EA; Orlicky D; Shroyer AL; McGregor JA; Shroyer KR Appl Immunohistochem Mol Morphol; 2002 Jun; 10(2):134-8. PubMed ID: 12051631 [TBL] [Abstract][Full Text] [Related]
2. Identification of survivin, an inhibitor of apoptosis, in canine urinary bladder transitional cell carcinoma. Rankin WV; Henry CJ; Turnquist SE; Turk JR; Beissenherz ME; Tyler JW; Rucker EB; Knapp DW; Rodriguez CO; Green JA Vet Comp Oncol; 2008 Sep; 6(3):141-50. PubMed ID: 19178674 [TBL] [Abstract][Full Text] [Related]
3. [Expression of Survivin in transitional cell carcinoma of urinary bladder and its clinical significance]. Xiao ZJ; Zheng S; Chen W; Zhang HF; Li CL; Gao YN Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(23):1977-9. PubMed ID: 15730809 [TBL] [Abstract][Full Text] [Related]
4. Comparison of distributions of survivin among tissues from urinary bladders of dogs with cystitis, transitional cell carcinoma, or histologically normal urinary bladders. Rankin WV; Henry CJ; Turnquist SE; Turk JR; Beissenherz ME; Tyler JW; Green JA Am J Vet Res; 2008 Aug; 69(8):1073-8. PubMed ID: 18672973 [TBL] [Abstract][Full Text] [Related]
5. Expression of survivin and its spliced variants in bladder tumors as a potential prognostic marker. Nouraee N; Mowla SJ; Ozhand A; Parvin M; Ziaee SA; Hatefi N Urol J; 2009; 6(2):101-8. PubMed ID: 19472128 [TBL] [Abstract][Full Text] [Related]
6. THE SIGNIFICANCE OF EPIDERMAL GROWTH FACTOR RECEPTOR AND SURVIVIN EXPRESSION IN BLADDER CANCER TISSUE AND URINE CYTOLOGY OF PATIENTS WITH TRANSITIONAL CELL CARCINOMA OF THE URINARY BLADDER. Kehinde EO; Al-Maghrebi M; Anim JT; Kapila K; George SS; Al-Juwaiser A; Memon A East Afr Med J; 2013 Jan; 90(1):19-27. PubMed ID: 26862626 [TBL] [Abstract][Full Text] [Related]
7. Differential expression of survivin and its splice variants, survivin-DeltaEx3 and survivin-2B, in bladder cancer. Atlasi Y; Mowla SJ; Ziaee SA Cancer Detect Prev; 2009; 32(4):308-13. PubMed ID: 19186007 [TBL] [Abstract][Full Text] [Related]
8. Expression of survivin does not predict survival in patients with transitional cell carcinoma of the upper urinary tract. Nakanishi K; Tominaga S; Hiroi S; Kawai T; Aida S; Kasamatsu H; Aurues T; Hayashi T; Ikeda T Virchows Arch; 2002 Dec; 441(6):559-63. PubMed ID: 12461612 [TBL] [Abstract][Full Text] [Related]
9. Expression and prognostic significance of survivin in the progression of bladder transitional cell cancer. Wang Y; Zhu Z; Zeng F; Wang L; Wu Y; Xia W; Xing S J Huazhong Univ Sci Technolog Med Sci; 2007 Aug; 27(4):444-7. PubMed ID: 17828507 [TBL] [Abstract][Full Text] [Related]
10. Survivin protein expression positively correlated with proliferative activity of cancer cells in bladder cancer. Wu Y; Wang G; Wei J; Wen X Indian J Med Sci; 2005 Jun; 59(6):235-42. PubMed ID: 15988093 [TBL] [Abstract][Full Text] [Related]
11. Promoter hypermethylation of the 14-3-3 sigma, SYK and CAGE-1 genes is related to the various phenotypes of urinary bladder carcinomas and associated with progression of transitional cell carcinomas. Kunze E; Wendt M; Schlott T Int J Mol Med; 2006 Oct; 18(4):547-57. PubMed ID: 16964403 [TBL] [Abstract][Full Text] [Related]
12. Survivin expression is associated with bladder cancer presence, stage, progression, and mortality. Shariat SF; Ashfaq R; Karakiewicz PI; Saeedi O; Sagalowsky AI; Lotan Y Cancer; 2007 Mar; 109(6):1106-13. PubMed ID: 17311310 [TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase-2 expression in urinary bladder transitional cell carcinoma and its association with clinicopathological characteristics. Tabriz HM; Olfati G; Ahmadi SA; Yusefnia S Asian Pac J Cancer Prev; 2013; 14(8):4539-43. PubMed ID: 24083698 [TBL] [Abstract][Full Text] [Related]
14. Uroplakin as a marker for typing metastatic transitional cell carcinoma on fine-needle aspiration specimens. Xu X; Sun TT; Gupta PK; Zhang P; Nasuti JF Cancer; 2001 Jun; 93(3):216-21. PubMed ID: 11391610 [TBL] [Abstract][Full Text] [Related]
15. E-cadherin expression in urothelial carcinoma in situ, superficial papillary transitional cell carcinoma, and invasive transitional cell carcinoma. Sun W; Herrera GA Hum Pathol; 2002 Oct; 33(10):996-1000. PubMed ID: 12395372 [TBL] [Abstract][Full Text] [Related]
16. Expression of survivin, a novel inhibitor of apoptosis, in superficial transitional cell carcinoma of the bladder. Ku JH; Kwak C; Lee HS; Park HK; Lee E; Lee SE J Urol; 2004 Feb; 171(2 Pt 1):631-5. PubMed ID: 14713775 [TBL] [Abstract][Full Text] [Related]
17. Expression of VEGF in urinary bladder transitional cell carcinoma in an Iraqi population subjected to depleted uranium: an immunohistochemical study. Al-Abbasi DS; Al-Janabi AA; Al-Toriahi KM; Jabor TA; Yasseen AA Appl Immunohistochem Mol Morphol; 2009 Jul; 17(4):307-11. PubMed ID: 19151604 [TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical analysis of bcl-2 expression in transitional cell carcinoma of the bladder. Shiina H; Igawa M; Urakami S; Honda S; Shirakawa H; Ishibe T J Clin Pathol; 1996 May; 49(5):395-9. PubMed ID: 8707954 [TBL] [Abstract][Full Text] [Related]
19. Silibinin down-regulates survivin protein and mRNA expression and causes caspases activation and apoptosis in human bladder transitional-cell papilloma RT4 cells. Tyagi AK; Agarwal C; Singh RP; Shroyer KR; Glode LM; Agarwal R Biochem Biophys Res Commun; 2003 Dec; 312(4):1178-84. PubMed ID: 14651997 [TBL] [Abstract][Full Text] [Related]
20. Frequent expression of zinc-finger protein ZNF165 in human urinary bladder transitional cell carcinoma. Singh PK; Srivastava AK; Dalela D; Rath SK; Goel MM; Bhatt ML Immunobiology; 2015 Jan; 220(1):68-73. PubMed ID: 25214475 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]